Video Latest - ecancer

Normal and neoplastic stem cells

Prof Irving L Weissman - Stanford University School of Medicine, Stanford, USA

26 Apr 2016

WIN 2016: Preview of themes

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

22 Apr 2016

WIN 2016: Preview of Speakers

Dr John Mendelsohn - Chairman of the WIN Consortium

22 Apr 2016

Update on new agents in multiple myeloma – focus on monoclonal antibodies: an expert roundtable discussion

Michel Delforge, Hermann Einsele, Philippe Moreau and Niels van de Donk

19 Apr 2016

Novel agents before and after stem cell transplantation for myeloma

Dr Enrique Ocio - Universidad de Salamanca, Salamanca, Spain

12 Apr 2016

Immunology highlights from the ITOC-3 conference

Prof Heinz Zwierzina - Innsbruck University, Innsbruck, Austria

12 Apr 2016

Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer

Prof Sine Reker Hadrup - Technical University of Denmark, Kongens Lyngby, Denmark

7 Apr 2016

Targeting AFP in hepatocellular cancer

Dr Lisa Butterfield University of Pittsburgh, Pittsburgh, USA

5 Apr 2016

Combination of viroimmunotherapy with checkpoint inhibitors

Prof Alan Melcher - The Institute of Cancer Research and The Royal Marsden Hospital, London, UK

4 Apr 2016

Is PD-L1 really a predictive biomarker?

Dr Paolo Ascierto - National Tumor Institute, Naples, Italy

4 Apr 2016

The role of microRNAs in modulation of the immune escape of tumors

Dr Barbara Seliger - Universitätsklinikum Halle , Saale, Germany

4 Apr 2016

Reprogramming the cancer microenvironment with vaccine-based therapy

Prof Lei Zheng - John Hopkins Institute Baltimore, USA

4 Apr 2016

Video